search
Back to results

3Mixtatin Versus Modified 3Mix-MP in Lesion Sterilization and Tissue Repair for Treatment of Necrotic Primary Molars (LSTR)

Primary Purpose

Necrotic Primary Molars

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
3Mixtatin paste: Simvastatin mixed with modified triple antibiotic
3Mix: Modified triple antibiotic mix in propylene glycol
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Necrotic Primary Molars focused on measuring 3MIX-MP, 3Mixtatin, LSTR

Eligibility Criteria

4 Years - 7 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Pediatric patients aged 4-7 years. Positive parental informed consent. Restorable necrotic mandibular second primary molars with peri-radicular/furcal involvement and/or pathologic root resorption (external or internal). Presence of chronic apical abscess or sinus tract or furcation radiolucency. (Thakur et al., 2021) Exclusion Criteria: Medically compromised children. Children with known allergy to any of the components being utilized. Molars near exfoliation. Molars with severely resorbed roots more than two thirds indicated for extraction Molars with insufficient coronal structure disabling proper coronal seal. Presence of periapical or interradicular radiolucent area which could compromise the permanent tooth bud. (Shetty et al., 2020)

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    (Group I Experimental Group):Simvastatin mixed with modified triple antibiotic (3Mixtatin)

    Group II Control group Modified triple antibiotic mix in propylene glycol (3Mix)

    Arm Description

    Patients will then be allocated into either one of the groups alternatively after access cavity preparation depending on the mix to be used as follows: for this group: 2mg of pure Simvastatin powder will be added to the 1:1:1 3Mix powder and will be stored together in an air tight porcelain container to avoid the exposure to moisture and light. Upon clinical application the 3Mixtatin powder will be mixed with normal saline to form a paste and is then applied in the same manner as the Modified 3Mix-MP paste.

    Removal of enteric coating/capsule of the three antibiotic tablets using a surgical blade. 500 mg Metronidazole tab 500 mg Ciprofloxacin tab 200 mg Cefixime caps Pulverization of each of the drug, will be done using a pestle & mortar, stored in an air tight porcelain container to avoid the exposure to moisture & light. Pulverized powders will be stored at a temperature of 16°C.Powder should be allowed to be cooled to the room temperature before initiating the preparation of 3Mix-MP paste. Powders will be mixed in the proportion of: 1:1:1 by volume (Hoshino et al., 1988). Vehicle that will be used is Systane eye drops (Kharadly et al., 2022) it contains the two main components propylene Glycol (Macrogol) & polyethylene glycol. The prepared antibiotic powder is mixed with the prepared vehicle in the ratio of 7:1 by volume. The two steps above are done after access cavity preparation to obtain a fresh mix.

    Outcomes

    Primary Outcome Measures

    Absence of pathological mobility measured by (Miller's grades)
    Miller's Classification Grade I: first distinguishable sign of movement Grade II: movement of tooth which allows crown to deviate 1mm of its normal position Grade III shows noticeable and increased movement of tooth more than 1mm in any direction or the tooth can be depressed into the socket. A reduction in grade of mobility from preoperative baseline will be considered as success while increased mobility will be recorded as failure
    Absence of pathological mobility measured by (Miller's grades)
    Miller's Classification Grade I: first distinguishable sign of movement Grade II: movement of tooth which allows crown to deviate 1mm of its normal position Grade III shows noticeable and increased movement of tooth more than 1mm in any direction or the tooth can be depressed into the socket. A reduction in grade of mobility from preoperative baseline will be considered as success while increased mobility will be recorded as failure
    Absence of pathological mobility measured by (Miller's grades)
    Miller's Classification Grade I: first distinguishable sign of movement Grade II: movement of tooth which allows crown to deviate 1mm of its normal position Grade III shows noticeable and increased movement of tooth more than 1mm in any direction or the tooth can be depressed into the socket. A reduction in grade of mobility from preoperative baseline will be considered as success while increased mobility will be recorded as failure
    Absence of pathological mobility measured by (Miller's grades)
    Miller's Classification Grade I: first distinguishable sign of movement Grade II: movement of tooth which allows crown to deviate 1mm of its normal position Grade III shows noticeable and increased movement of tooth more than 1mm in any direction or the tooth can be depressed into the socket. A reduction in grade of mobility from preoperative baseline will be considered as success while increased mobility will be recorded as failure
    Absence of post-operative pain (binary)
    Measured by asking the patient to identify presence or absence of pain
    Absence of post-operative pain (binary)
    Measured by asking the patient to identify presence or absence of pain
    Absence of post-operative pain (binary)
    Measured by asking the patient to identify presence or absence of pain
    Absence of post-operative pain (binary)
    Measured by asking the patient to identify presence or absence of pain
    Absence of soft tissue pathologies (binary)
    Binary outcome measured visually by intraoral/extraoral examination
    Absence of soft tissue pathologies (binary)
    Binary outcome measured visually by intraoral/extraoral examination
    Absence of soft tissue pathologies (binary)
    Binary outcome measured visually by intraoral/extraoral examination
    Absence of soft tissue pathologies (binary)
    Binary outcome measured visually by intraoral/extraoral examination
    Absence of pain on percussion (binary)
    Binary outcome measured by gentle tapping using the back of the mirror on the tooth
    Absence of pain on percussion (binary)
    Binary outcome measured by gentle tapping using the back of the mirror on the tooth
    Absence of pain on percussion (binary)
    Binary outcome measured by gentle tapping using the back of the mirror on the tooth
    Absence of pain on percussion (binary)
    Binary outcome measured by gentle tapping using the back of the mirror on the tooth

    Secondary Outcome Measures

    Status of radiolucency if present at the periapical or at furcation area
    Comparison between pre-operative radiolucency and at follow up periods post-operatively to asses bone regeneration. Results will be recorded as Static-Increased-Decreased using customized stent for xray and Digora software for measurements.
    Status of radiolucency if present at the periapical or at furcation area
    Comparison between pre-operative radiolucency and at follow up periods post-operatively to asses bone regeneration. Results will be recorded as Static-Increased-Decreased using customized stent for xray and Digora software for measurements.
    Status of radiolucency if present at the periapical or at furcation area
    Comparison between pre-operative radiolucency and at follow up periods post-operatively to asses bone regeneration. Results will be recorded as Static-Increased-Decreased using customized stent for xray and Digora software for measurements.
    Absence of external or internal root resorption
    Binary outcome measured by comparing pre-operative x-ray with baseline and follow up x-rays. using customized stent

    Full Information

    First Posted
    December 15, 2022
    Last Updated
    December 25, 2022
    Sponsor
    Cairo University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05677945
    Brief Title
    3Mixtatin Versus Modified 3Mix-MP in Lesion Sterilization and Tissue Repair for Treatment of Necrotic Primary Molars
    Acronym
    LSTR
    Official Title
    A Randomized Controlled Trial Comparing the Clinical and Radiographic Success of 3Mixtatin Versus Modified 3Mix in Lesion Sterilization and Tissue Repair (LSTR) for The Treatment of Necrotic Primary Molars
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    March 2023 (Anticipated)
    Primary Completion Date
    March 2024 (Anticipated)
    Study Completion Date
    August 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Cairo University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    This randomized clinical study aims to assess the clinical and radiographic success rate of the 3Mixtatin versus the 3Mix in LSTR in necrotic primary molars.
    Detailed Description
    Research question: In necrotic primary molars with peri-radicular lesions and/or external root, resorption does adding Simvastatin to the triple antibiotic mix have higher clinical and radiographic success than the triple antibiotic paste solely? Statement of the problem: Primary teeth with necrotic pulp and extensive root resorption and/or furcal radiolucency are not uncommon scenarios that pediatric dentists are exposed to. Such clinical and radiographic presentations contraindicate the application of conventional pulpectomy treatment. Lesion Sterilization and Tissue Repair (LSTR) is an approach that has shown promising results in maintaining such teeth for up to 12 months. Primary teeth serve as a natural space maintainer, enable normal and healthy functioning of the child, and eliminate the chances for malocclusion and growth pattern disruptions. LSTR offers practitioners a promising option to save those teeth when all other treatment options seem impossible. The Rationale for Conducting the Research: In accordance to the popularity that LSTR has recently been gaining in the field of Pediatric dentistry, an abundance of studies have been conducted in the recent years. Researchers are striving to explore the plethora of possibilities and variances in the LSTR technique that could help clinicians practice better and achieve more for their patients. Amongst the alternatives is the recent and common detour towards regenerative dentistry. Simvastatin, one of the materials, remains of high interest to the field due to its healing powers. However, to our knowledge insufficient studies are available on the direct comparison of the clinical and radiographic success including bone regeneration using the 3Mixtatin versus 3Mix alone. Furthermore, studies conducted warrant the need for further studies directly comparing 3Mixtatin with 3mix. Therefore, this study aims to come to a conclusion on whether the 3mix with the host's body defense and repair mechanism are sufficient to save a necrotic primary tooth or is some help in bone regeneration and healing promotion needed. The LSTR technique involves non-instrumentation or minimal instrumentation followed by sterilization of the infected pulpal space by the placement of a triple antibiotic mixture in a propylene glycol vehicle to disinfect the microbial flora inhabiting the infected root canal systems and peri-apical lesions. The latter step achieves disinfection while tissue repair is then allowed to take place by the host's natural body defense mechanisms The triple antibiotic paste (TAP/3mix), is an intracanal medicament that has continuously proven its efficacy and superiority for years against the microflora inhabiting necrotic canals predominantly Enterococcus Faecalis, the most prevalent organism in infected root canals. Metronidazole, ciprofloxacin, and minocycline, the oldest and most common combination suggested by Takushige et al., has been subjected to many studies and changes due to the discoloration caused by minocycline. As a result of, modified triple antibiotic paste (Modified-3mix) was introduced to replace minocycline with clindamycin. Statins are antihyperlipidemic drugs, with a bio inductive feature that includes inhibition of bone resorption and promotion of osteoblast proliferation and differentiation as well as stimulating angiogenesis all of which aid in the healing process. In a clinical trial mixing modified 3mix with statins in, namely, Simvastatin; resulted in excellent clinical and radiographic success rates. Hence, modifying the LSTR technique to include regenerative materials such as statin is an extremely promising area of research.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Necrotic Primary Molars
    Keywords
    3MIX-MP, 3Mixtatin, LSTR

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigatorOutcomes Assessor
    Masking Description
    This research will be a double-blinded study, where the patient (participant) and the outcome assessor will be blinded to the treatment group (to avoid detection, reporting and assessment bias). When a patient agrees to participate in the trial, an envelope will be drawn by one of the residents present at the clinic and name, telephone number and patient's I.D. will be written on it. Those selected envelops will be opened at treatment visit after performing access cavity to choose which material should be used. Randomization and allocation concealment will be performed by the co-supervisor to avoid selection bias. The participant will not be aware of which treatment modality he will be receiving. Principal investigator will not be blinded due to differences in preparation of the mix.
    Allocation
    Randomized
    Enrollment
    24 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    (Group I Experimental Group):Simvastatin mixed with modified triple antibiotic (3Mixtatin)
    Arm Type
    Experimental
    Arm Description
    Patients will then be allocated into either one of the groups alternatively after access cavity preparation depending on the mix to be used as follows: for this group: 2mg of pure Simvastatin powder will be added to the 1:1:1 3Mix powder and will be stored together in an air tight porcelain container to avoid the exposure to moisture and light. Upon clinical application the 3Mixtatin powder will be mixed with normal saline to form a paste and is then applied in the same manner as the Modified 3Mix-MP paste.
    Arm Title
    Group II Control group Modified triple antibiotic mix in propylene glycol (3Mix)
    Arm Type
    Active Comparator
    Arm Description
    Removal of enteric coating/capsule of the three antibiotic tablets using a surgical blade. 500 mg Metronidazole tab 500 mg Ciprofloxacin tab 200 mg Cefixime caps Pulverization of each of the drug, will be done using a pestle & mortar, stored in an air tight porcelain container to avoid the exposure to moisture & light. Pulverized powders will be stored at a temperature of 16°C.Powder should be allowed to be cooled to the room temperature before initiating the preparation of 3Mix-MP paste. Powders will be mixed in the proportion of: 1:1:1 by volume (Hoshino et al., 1988). Vehicle that will be used is Systane eye drops (Kharadly et al., 2022) it contains the two main components propylene Glycol (Macrogol) & polyethylene glycol. The prepared antibiotic powder is mixed with the prepared vehicle in the ratio of 7:1 by volume. The two steps above are done after access cavity preparation to obtain a fresh mix.
    Intervention Type
    Drug
    Intervention Name(s)
    3Mixtatin paste: Simvastatin mixed with modified triple antibiotic
    Intervention Description
    Drying the mucosa with gauze,topical anesthesia will be applied. Administration of local anesthesia with vasoconstrictor. Rubber dam isolation. Caries removal & access cavity using a round bur mounted on a high-speed contra with coolant. Removal of necrotic pulp tissue in coronal portion of the tooth using sharp excavator. Radicular section will be kept untouched,no instrumentation. Using disposable syringe Irrigation of the pulp chamber with 2.5% NaOCl. In case of hemorrhage moist cotton immersed in 1% NaOCL will be placed to achieve hemostasis. Drying the access cavity with sterile cotton pellets. Freshly mixed 3Mix-MP or 3Mixtatin paste (according to group of intervention) will be transferred to the floor of the pulp chamber using an amalgam carrier & condensed over orifices using a moist cotton pellet. Cavity sealing with RMGI capsules. Same visit placement with preformed Stainless-steel crown(3M® ESPE)cemented with glass ionomer cement.
    Intervention Type
    Drug
    Intervention Name(s)
    3Mix: Modified triple antibiotic mix in propylene glycol
    Intervention Description
    Drying the mucosa with gauze,topical anesthesia will be applied. Administration of local anesthesia with vasoconstrictor. Rubber dam isolation. Caries removal & access cavity using a round bur mounted on a high-speed contra with coolant. Removal of necrotic pulp tissue in coronal portion of the tooth using sharp excavator. Radicular section will be kept untouched,no instrumentation. Using disposable syringe Irrigation of the pulp chamber with 2.5% NaOCl. In case of hemorrhage moist cotton immersed in 1% NaOCL will be placed to achieve hemostasis. Drying the access cavity with sterile cotton pellets. Freshly mixed 3Mix-MP or 3Mixtatin paste (according to group of intervention) will be transferred to the floor of the pulp chamber using an amalgam carrier & condensed over orifices using a moist cotton pellet. Cavity sealing with RMGI capsules. Same visit placement with preformed Stainless-steel crown(3M® ESPE)cemented with glass ionomer cement.
    Primary Outcome Measure Information:
    Title
    Absence of pathological mobility measured by (Miller's grades)
    Description
    Miller's Classification Grade I: first distinguishable sign of movement Grade II: movement of tooth which allows crown to deviate 1mm of its normal position Grade III shows noticeable and increased movement of tooth more than 1mm in any direction or the tooth can be depressed into the socket. A reduction in grade of mobility from preoperative baseline will be considered as success while increased mobility will be recorded as failure
    Time Frame
    baseline
    Title
    Absence of pathological mobility measured by (Miller's grades)
    Description
    Miller's Classification Grade I: first distinguishable sign of movement Grade II: movement of tooth which allows crown to deviate 1mm of its normal position Grade III shows noticeable and increased movement of tooth more than 1mm in any direction or the tooth can be depressed into the socket. A reduction in grade of mobility from preoperative baseline will be considered as success while increased mobility will be recorded as failure
    Time Frame
    at 3 months post operative
    Title
    Absence of pathological mobility measured by (Miller's grades)
    Description
    Miller's Classification Grade I: first distinguishable sign of movement Grade II: movement of tooth which allows crown to deviate 1mm of its normal position Grade III shows noticeable and increased movement of tooth more than 1mm in any direction or the tooth can be depressed into the socket. A reduction in grade of mobility from preoperative baseline will be considered as success while increased mobility will be recorded as failure
    Time Frame
    at 6 months post operative
    Title
    Absence of pathological mobility measured by (Miller's grades)
    Description
    Miller's Classification Grade I: first distinguishable sign of movement Grade II: movement of tooth which allows crown to deviate 1mm of its normal position Grade III shows noticeable and increased movement of tooth more than 1mm in any direction or the tooth can be depressed into the socket. A reduction in grade of mobility from preoperative baseline will be considered as success while increased mobility will be recorded as failure
    Time Frame
    at 12 months post operative
    Title
    Absence of post-operative pain (binary)
    Description
    Measured by asking the patient to identify presence or absence of pain
    Time Frame
    baseline
    Title
    Absence of post-operative pain (binary)
    Description
    Measured by asking the patient to identify presence or absence of pain
    Time Frame
    at 3 months post operative
    Title
    Absence of post-operative pain (binary)
    Description
    Measured by asking the patient to identify presence or absence of pain
    Time Frame
    at 6 months post operative
    Title
    Absence of post-operative pain (binary)
    Description
    Measured by asking the patient to identify presence or absence of pain
    Time Frame
    at 12 months post operative
    Title
    Absence of soft tissue pathologies (binary)
    Description
    Binary outcome measured visually by intraoral/extraoral examination
    Time Frame
    baseline
    Title
    Absence of soft tissue pathologies (binary)
    Description
    Binary outcome measured visually by intraoral/extraoral examination
    Time Frame
    at 3 months post operative
    Title
    Absence of soft tissue pathologies (binary)
    Description
    Binary outcome measured visually by intraoral/extraoral examination
    Time Frame
    at 6 months post operative
    Title
    Absence of soft tissue pathologies (binary)
    Description
    Binary outcome measured visually by intraoral/extraoral examination
    Time Frame
    at 12 months post operative
    Title
    Absence of pain on percussion (binary)
    Description
    Binary outcome measured by gentle tapping using the back of the mirror on the tooth
    Time Frame
    baseline
    Title
    Absence of pain on percussion (binary)
    Description
    Binary outcome measured by gentle tapping using the back of the mirror on the tooth
    Time Frame
    at 3 months post operative
    Title
    Absence of pain on percussion (binary)
    Description
    Binary outcome measured by gentle tapping using the back of the mirror on the tooth
    Time Frame
    at 6 months post operative
    Title
    Absence of pain on percussion (binary)
    Description
    Binary outcome measured by gentle tapping using the back of the mirror on the tooth
    Time Frame
    at 12 months post operative
    Secondary Outcome Measure Information:
    Title
    Status of radiolucency if present at the periapical or at furcation area
    Description
    Comparison between pre-operative radiolucency and at follow up periods post-operatively to asses bone regeneration. Results will be recorded as Static-Increased-Decreased using customized stent for xray and Digora software for measurements.
    Time Frame
    baseline
    Title
    Status of radiolucency if present at the periapical or at furcation area
    Description
    Comparison between pre-operative radiolucency and at follow up periods post-operatively to asses bone regeneration. Results will be recorded as Static-Increased-Decreased using customized stent for xray and Digora software for measurements.
    Time Frame
    at 6 months post operative
    Title
    Status of radiolucency if present at the periapical or at furcation area
    Description
    Comparison between pre-operative radiolucency and at follow up periods post-operatively to asses bone regeneration. Results will be recorded as Static-Increased-Decreased using customized stent for xray and Digora software for measurements.
    Time Frame
    at 12 months post operative
    Title
    Absence of external or internal root resorption
    Description
    Binary outcome measured by comparing pre-operative x-ray with baseline and follow up x-rays. using customized stent
    Time Frame
    baseline , 6 ,12 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    4 Years
    Maximum Age & Unit of Time
    7 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Pediatric patients aged 4-7 years. Positive parental informed consent. Restorable necrotic mandibular second primary molars with peri-radicular/furcal involvement and/or pathologic root resorption (external or internal). Presence of chronic apical abscess or sinus tract or furcation radiolucency. (Thakur et al., 2021) Exclusion Criteria: Medically compromised children. Children with known allergy to any of the components being utilized. Molars near exfoliation. Molars with severely resorbed roots more than two thirds indicated for extraction Molars with insufficient coronal structure disabling proper coronal seal. Presence of periapical or interradicular radiolucent area which could compromise the permanent tooth bud. (Shetty et al., 2020)
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Dalia Magdy Al Shamy, BSC
    Phone
    01023363613
    Ext
    002
    Email
    dalia.elshamy@dentistry.cu.edu.eg
    First Name & Middle Initial & Last Name or Official Title & Degree
    Maii Mohamed, lecturer
    Phone
    01012632608
    Ext
    002
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Rania Nasr, Professor
    Organizational Affiliation
    Professor of pediatric dentistry
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    35645497
    Citation
    Chak RK, Singh RK, Mutyala J, Killi NK. Clinical Radiographic Evaluation of 3Mixtatin and MTA in Primary Teeth Pulpotomies: A Randomized Controlled. Int J Clin Pediatr Dent. 2022;15(Suppl 1):S80-S86. doi: 10.5005/jp-journals-10005-2216.
    Results Reference
    background
    PubMed Identifier
    9206436
    Citation
    Hoshino E, Kurihara-Ando N, Sato I, Uematsu H, Sato M, Kota K, Iwaku M. In-vitro antibacterial susceptibility of bacteria taken from infected root dentine to a mixture of ciprofloxacin, metronidazole and minocycline. Int Endod J. 1996 Mar;29(2):125-30. doi: 10.1111/j.1365-2591.1996.tb01173.x.
    Results Reference
    background
    PubMed Identifier
    3052845
    Citation
    Hoshino E, Kota K, Sato M, Iwaku M. Bactericidal efficacy of metronidazole against bacteria of human carious dentin in vitro. Caries Res. 1988;22(5):280-2. doi: 10.1159/000261121.
    Results Reference
    background
    PubMed Identifier
    26950808
    Citation
    Aminabadi NA, Huang B, Samiei M, Agheli S, Jamali Z, Shirazi S. A Randomized Trial Using 3Mixtatin Compared to MTA in Primary Molars with Inflammatory Root Resorption: A Novel Endodontic Biomaterial. J Clin Pediatr Dent. 2016;40(2):95-102. doi: 10.17796/1053-4628-40.2.95.
    Results Reference
    background
    PubMed Identifier
    30787561
    Citation
    Sain S, J R, S A, George S, S Issac J, A John S. Lesion Sterilization and Tissue Repair-Current Concepts and Practices. Int J Clin Pediatr Dent. 2018 Sep-Oct;11(5):446-450. doi: 10.5005/jp-journals-10005-1555. Epub 2018 Oct 1.
    Results Reference
    background
    PubMed Identifier
    14871180
    Citation
    Takushige T, Cruz EV, Asgor Moral A, Hoshino E. Endodontic treatment of primary teeth using a combination of antibacterial drugs. Int Endod J. 2004 Feb;37(2):132-8. doi: 10.1111/j.0143-2885.2004.00771.x.
    Results Reference
    background
    PubMed Identifier
    35003558
    Citation
    Thakur S, Deep A, Singhal P, Chauhan D. A randomized control trial comparing the efficacy of 3Mixtatin and Modified 3Mix-MP paste using lesion sterilization and tissue repair technique to conventional root canal treatment in primary molars of children aged 4-8 years: An in vivo study. Dent Res J (Isfahan). 2021 Nov 22;18:93. doi: 10.4103/1735-3327.330874. eCollection 2021.
    Results Reference
    background

    Learn more about this trial

    3Mixtatin Versus Modified 3Mix-MP in Lesion Sterilization and Tissue Repair for Treatment of Necrotic Primary Molars

    We'll reach out to this number within 24 hrs